Jessica Petrick PhD, MPH

Assistant Professor, Hematology & Medical Oncology

Center Faculty Member, Slone Epidemiology Center

72 E. Concord Street | (617) 206-6179
Jessica Petrick
Sections

Hematology & Medical Oncology

Centers

BU-BMC Cancer Center

Evans Center for Interdisciplinary Biomedical Research

Biography

Dr. Jessica Petrick’s research program focuses on the epidemiology of gastrointestinal cancers, including colorectal, liver, and esophageal. Dr. Petrick became a co-Investigator with the Black Women’s Health Study (BWHS) in 2019, but she has been collaborating with BWHS since she began her post-doctoral fellowship at the National Cancer Institute (NCI) in 2014. BWHS is a member of the NCI Cancer Cohort Consortium and participated in the Liver Cancer Pooling Project, within which Dr. Petrick led numerous studies. The emphasis of her current research portfolio is on nutritional and molecular factors, including the metabolome and microbiome, which may contribute to racial disparities along the cancer continuum—from precursor lesions to invasive cancer through mortality.

Education

Epidemiology, PhD, University of North Carolina

Epidemiology/Health Policy, MPH, Case Western Reserve University

Public Health/Medical Anthropology, BS, Case Western Reserve University

Publications

Published on 5/21/2025

Watling CZ, Petrick JL, Graubard BI, Zhang X, Barnett MJ, Buring JE, Chen Y, Eliassen AH, Gaziano M, Kang JH, Koshiol J, Huang WY, Lee IM, Moore SC, Mucci LA, Neuhouser ML, Newton CC, Palmer JR, Rosenberg L, Sesso HD, Shrubsole M, Tinker L, Triplette M, Um CY, Visvanathan K, Wactawski-Wende J, Willett W, Wu F, Zheng W, Hofmann J, Purdue MP, Campbell PT, Barupal D, McGlynn KA. Circulating per- and polyfluoroalkyl substances and liver cancer risk: a nested case-control analysis of individual participant data from 12 prospective cohorts. Environ Health Perspect. 2025 May 21. PMID: 40397817.

Published on 5/2/2025

Omofuma OO, Rusiecki JA, Petrick JL, Falk RT, Wheeler W, Pfeiffer RM, Camargo MC, Cook MB. Circulating Inflammation Biomarkers and the Risk of Esophageal Adenocarcinoma: A Nested Case-Control Study in the Department of Defense Serum Repository. Cancer Epidemiol Biomarkers Prev. 2025 May 02; 34(5):649-657. PMID: 40079721.

Published on 4/28/2025

Liu X, Zhang X, Zhao L, Petrick JL, Liao LM, Wang W, He N, Giovannucci E, Zhang ZF, McGlynn KA, Zhang X. The associations between dairy intake and chronic liver disease mortality and liver cancer incidence: a prospective cohort study. Am J Clin Nutr. 2025 Apr 28. PMID: 40306387.

Published on 3/12/2025

Watling CZ, Wojt A, Florio AA, Butera G, Albanes D, Weinstein SJ, Huang WY, Parisi D, Zhang X, Graubard BI, Petrick JL, McGlynn KA. Reply: Fiber and whole grain intakes in relation to liver cancer risk-An analysis in 2 prospective cohorts and systematic review and meta-analysis of prospective studies. Hepatology. 2025 Mar 12. PMID: 40073273.

Published on 2/14/2025

Watling CZ, Hua X, Petrick JL, Zhang X, Do WL, Wang L, Maestri E, Yu K, Wang XW, McGlynn KA. Pan-serological antibodies and liver cancer risk: a nested case-control analysis. Sci Rep. 2025 Feb 14; 15(1):5450. PMID: 39953193.

Published on 1/23/2025

Shan Y, Bertrand KA, Petrick JL, Sheehy S, Palmer JR. Planetary Health Diet Index in relation to mortality in a prospective cohort study of United States Black females. Am J Clin Nutr. 2025 Mar; 121(3):589-596. PMID: 39863116.

Published on 11/5/2024

Watling CZ, Kelly RK, Watts EL, Graubard BI, Petrick JL, Matthews CE, McGlynn KA. Total testosterone, sex hormone-binding globulin, and free testosterone concentrations and risk of primary liver cancer: A prospective analysis of 200,000 men and 180,000 postmenopausal women. Int J Cancer. 2025 Apr 15; 156(8):1518-1528. PMID: 39499225.

Published on 10/2/2024

McGlynn KA, Petrick JL, Groopman JD. Liver Cancer: Progress and Priorities. Cancer Epidemiol Biomarkers Prev. 2024 Oct 02; 33(10):1261-1272. PMID: 39354815.

Published on 7/29/2024

Zamani SA, Graubard BI, Hyer M, Carver E, Petrick JL, McGlynn KA. Use of cholesterol-lowering medications in relation to risk of primary liver cancer in the Clinical Practice Research Datalink. Cancer. 2024 Oct 15; 130(20):3506-3518. PMID: 39072717.

Published on 3/5/2024

Watling CZ, Wojt A, Florio AA, Butera G, Albanes D, Weinstein SJ, Huang WY, Parisi D, Zhang X, Graubard BI, Petrick JL, McGlynn KA. Fiber and whole grain intakes in relation to liver cancer risk: An analysis in 2 prospective cohorts and systematic review and meta-analysis of prospective studies. Hepatology. 2024 Sep 01; 80(3):552-565. PMID: 38441973.

View full list of 106 publications.